Claudin18.2 and the PD-1/PD-L1 axis in gastric cancer: mechanistic insights and implications for combination immunotherapy

This narrative review was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on title and PubMed metadata review. It appears low priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

This narrative review was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on title and PubMed metadata review. It appears low priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.

What the study was

Study design

Narrative review

Maturity

Exploratory

Journal

Journal of translational medicine

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.